Medicamen Biotech Limited (MEDICAMEQ) — Tangible Net Worth Ratio
Medicamen Biotech Limited (MEDICAMEQ) has a Tangible Net Worth Ratio of 99.8% as of March 2026. This metric is calculated by deducting intangible assets (Rs5.72 Million) from net assets (Rs2.76 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Medicamen Biotech Limited (MEDICAMEQ) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Medicamen Biotech Limited Tangible Net Worth Ratio (2006–2026)
This chart shows how Medicamen Biotech Limited's Tangible Net Worth Ratio has changed across 21 annual periods from 2006 to 2026. As of March 2026, the ratio stands at 99.8%, reflecting net assets of Rs2.76 Billion with intangible assets of Rs5.72 Million INR. For live market cap and overall valuation, see MEDICAMEQ market cap.
Annual Tangible Net Worth Ratio for Medicamen Biotech Limited (2006–2026)
The table below presents the year-by-year Tangible Net Worth Ratio for Medicamen Biotech Limited from 2006 to 2026, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Medicamen Biotech Limited capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (INR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 99.8% | Rs2.76 Billion | Rs5.72 Million | Rs3.72 Billion | ▲ +0.1 pp |
| 2025 | 99.7% | Rs2.13 Billion | Rs7.42 Million | Rs2.97 Billion | ▲ +0.1 pp |
| 2024 | 99.6% | Rs2.07 Billion | Rs8.98 Million | Rs2.95 Billion | ▲ +0.0 pp |
| 2023 | 99.5% | Rs1.93 Billion | Rs8.98 Million | Rs2.79 Billion | ▼ -0.2 pp |
| 2022 | 99.8% | Rs1.46 Billion | Rs3.60 Million | Rs2.26 Billion | ▼ -0.1 pp |
| 2021 | 99.8% | Rs1.33 Billion | Rs2.04 Million | Rs1.94 Billion | ▲ +0.1 pp |
| 2020 | 99.8% | Rs1.21 Billion | Rs2.69 Million | Rs1.81 Billion | ▲ +0.2 pp |
| 2019 | 99.6% | Rs866.34 Million | Rs3.34 Million | Rs1.37 Billion | ▲ +0.0 pp |
| 2018 | 99.6% | Rs746.08 Million | Rs3.17 Million | Rs1.18 Billion | ▼ -0.3 pp |
| 2017 | 99.9% | Rs267.81 Million | Rs217.88K | Rs734.01 Million | ▲ +0.1 pp |
| 2016 | 99.8% | Rs179.09 Million | Rs307.44K | Rs600.18 Million | ▲ +0.1 pp |
| 2015 | 99.8% | Rs171.85 Million | Rs397.00K | Rs686.63 Million | ▲ +0.2 pp |
| 2014 | 99.5% | Rs165.38 Million | Rs761.57K | Rs645.79 Million | ▲ +0.3 pp |
| 2013 | 99.3% | Rs157.17 Million | Rs1.18 Million | Rs652.34 Million | ▲ +0.0 pp |
| 2012 | 99.2% | Rs201.01 Million | Rs1.53 Million | Rs689.07 Million | ▼ -0.8 pp |
| 2011 | 100.0% | Rs204.12 Million | Rs0.00 | Rs700.18 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Rs162.61 Million | Rs0.00 | Rs576.83 Million | ▲ +0.0 pp |
| 2009 | 100.0% | Rs129.60 Million | Rs0.00 | Rs458.11 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Rs115.83 Million | Rs0.00 | Rs517.72 Million | ▲ +0.0 pp |
| 2007 | 100.0% | Rs100.73 Million | Rs0.00 | Rs464.17 Million | ▲ +0.0 pp |
| 2006 | 100.0% | Rs85.67 Million | Rs0.00 | Rs338.18 Million | — |